NL-OMON24924已完成不适用
Botulinum toxin A in the treatment of orofacial tardive dyskinesias: a single blind study.
Botulinum toxin A ampules by Ipsen, pharmaceutical group0 个研究点目标入组 14 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 14
研究概览
简要总结
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):507-9. Epub 2007 Oct 13.
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients suffering from orofacial tardive dyskinisias for at least 3 months, stable dosage of psychopharmacological medication and written informed consent by the patient.
排除标准
- •Age younger than 18 years, contraindication for botulinum toxin (myasthenia gravis, Lambert Eaton Myasthenic Syndrome) and women known to be pregnant or having a positive pregnancy test.
研究者
相似试验
已完成
不适用
Botulinum toxin in the treatment of orofacial tardive dyskinesias: a single blind studyTardive dyskinesiaDystoniaISRCTN81508784Parnassia Psycho-medical Centre (Netherlands)14
已完成
2 期
Botulinum toxin treatment for orofacial pain, bruxism or occlusal dysesthesia: (phase 2 patient study) Effect for the patientsorofacial pain, bruxism, occlusal dysethesiaJPRN-UMIN000009827Tokushima University Hospital4
进行中（未招募）
不适用
Botulinum toxin treatment in hyperhidrosis (excessive sweating).Hyperhidrosis-craniofacial, inguinal, palmar, plantar and truncal.MedDRA version: 17.1Level: PTClassification code 10020642Term: HyperhidrosisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2011-003132-30-SESvettmottagningen Hidroskliniken, Stockholm
已完成
2 期
Botulinum Toxin in Burning Mouth SyndromeBurning Mouth SyndromeNCT02964728Presidio Ospedaliero Garibaldi-Centro6
已完成
2 期
Intraoral Administration of Botox in Patients With Dentoalveolar Neuropathic PainNeuropathic PainNCT03848143Isabel Moreno Hay8